Role of antihypertensive medicines in prostate cancer: A systematic review
Số trang: 11
Loại file: pdf
Dung lượng: 1.22 MB
Lượt xem: 6
Lượt tải: 0
Xem trước 2 trang đầu tiên của tài liệu này:
Thông tin tài liệu:
Hypertension is associated with the risk of prostate cancer (PCa) and its progression, however, it remains unclear whether antihypertensive medicines alter PCa risk or prognosis. This systematic review evaluated the role of calcium channel blockers (CCBs) and renin-angiotensin system (RAS) inhibitors in the risk and prognosis of PCa. This review was performed in line with PRISMA 2020 guidelines.
Nội dung trích xuất từ tài liệu:
Role of antihypertensive medicines in prostate cancer: A systematic review
Nội dung trích xuất từ tài liệu:
Role of antihypertensive medicines in prostate cancer: A systematic review
Tìm kiếm theo từ khóa liên quan:
BMC Cancer Prostate cancer Antihypertensive medicines Angiotensin receptor blockers Calcium channel blockers Renin-angiotensin inhibitors Angiotensin-converting enzyme inhibitorsTài liệu liên quan:
-
Differences between physician and patient preferences for cancer treatments: A systematic review
13 trang 175 0 0 -
6 trang 169 0 0
-
Immune checkpoint inhibitors and their impact on liver enzymes and attenuation
7 trang 147 0 0 -
2011–2021 rising prevalence of HPV infection among oropharyngeal carcinoma in France
9 trang 125 0 0 -
12 trang 98 0 0
-
19 trang 76 0 0
-
17 trang 68 0 0
-
9 trang 46 0 0
-
12 trang 40 0 0
-
Investigating the prognostic and predictive value of the type II cystatin genes in gastric cancer
17 trang 39 0 0